4//SEC Filing
LIEBMAN SEYMOUR 4
Accession 0000899243-21-026534
CIK 0001492674other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 2:59 PM ET
Size
9.3 KB
Accession
0000899243-21-026534
Insider Transaction Report
Form 4
LIEBMAN SEYMOUR
Director
Transactions
- Award
Restricted Stock Units
2021-06-25+73,224→ 73,224 total→ Common Stock (73,224 underlying) - Exercise/Conversion
Common Stock
2021-06-25+45,454→ 129,639 total - Exercise/Conversion
Restricted Stock Units
2021-06-25−45,454→ 45,454 total→ Common Stock (45,454 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]On August 6, 2020 the reporting person was granted 45,454 restricted stock units that vested on June 25, 2021.
- [F3]The restricted stock units vest in one installment on the earlier of (i) June 25, 2022 and (ii) the date of the next annual meeting of stockholders.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001252287
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 2:59 PM ET
- Size
- 9.3 KB